Listed by the Federal Institute for Drugs and Medical Devices (BfArM) as a rapid test for direct pathogen detection of the coronavirus SARS-CoV-2.
This profit test has been positively evaluated at the Paul Ehrlich Institute (PEI).
The WIZBIOTECH® SARS-CoV-2 Antigen Rapid Test as a saliva test for the detection of infection with the virus causing Covid-19. The test consists of antibodies that are able to recognise the antigens of the virus responsible for Covid-19. It enables rapid and efficient detection of infection with the coronavirus (SARS-CoV-2) within 15 minutes.
The WIZBIOTECH® SARS-CoV-2 Antigen Rapid Test (Saliva) is intended for the qualitative detection of SARS-CoV-2 antigens (nucleocapsid protein) in human saliva samples invitro.
Application:
- Saliva test
- fast and reliable test results in only 15 minutes
BfArM: AT240/21
Paul-Ehrlich-Institut: positively evaluated
Performance data:
Specificity = 100 %
Sensitivity = 95.35 %
Scope of delivery:
25x test cassette
25x extraction tube with 0.5ml buffer
25x sterile swab
25x disposable spittoon bag
1x work station
1x instruction manual
1Unit = 25pcs/box - 1box = 500pcs. (20boxes/carton)
For use by healthcare professionals only